Director Fromkin Andrew J. sold Immunovant Inc. ($IMVT) shares on the open market twice in the last 365 days, totaling about $517,000. His most recent sale occurred on December 1, 2025. These sales rank 6,358th among 11,678 individual insiders, below the average sale amount of $8.6 million across 6.4 transactions. He made no open market purchases during this period.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 1, 2025 | Immunovant, Inc. | $IMVT | Fromkin Andrew J. | Director | S | Common Stock | 2898 | $23.95 | 85,852.0000 | 175,276,526 | 3.27% | 0.00% |
| Dec. 1, 2025 | Immunovant, Inc. | $IMVT | Fromkin Andrew J. | Director | S | Common Stock | 19351 | $23.14 | 88,750.0000 | 175,276,526 | 17.90% | 0.01% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Fromkin Andrew J. | Director | A | Common Stock | 16188 | $0.00 | 108,101.0000 | 0 | 17.61% | 0.00% |
| April 1, 2025 | Immunovant, Inc. | $IMVT | Fromkin Andrew J. | Director | A | Stock Option (right to buy) | 7600 | $0.00 | 7,600.0000 | 0 | 9999.99% | 0.00% |
| March 7, 2025 | Immunovant, Inc. | $IMVT | Fromkin Andrew J. | Director | S | Common Stock | 1384 | $19.96 | 91,913.0000 | 0 | 1.48% | 0.00% |
| March 7, 2025 | Immunovant, Inc. | $IMVT | Fromkin Andrew J. | Director | S | Common Stock | 6616 | $19.52 | 93,297.0000 | 0 | 6.62% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Fromkin Andrew J. | Director | A | Common Stock | 11255 | $0.00 | 99,913.0000 | 0 | 12.69% | 0.00% |
| April 2, 2024 | Immunovant, Inc. | $IMVT | Fromkin Andrew J. | Director | A | Stock Option (right to buy) | 4690 | $0.00 | 4,690.0000 | 0 | 9999.99% | 0.00% |